Efficacy of Oral Vancomycin in Preventing RecurrentClostridium difficileInfection in Patients Treated With Systemic Antimicrobial Agents: Table 1. | Zendy

Nicholas W. Van Hise | Zendy; Alex Bryant | Zendy; Erin Hennessey | Zendy; Andrew J. Crannage | Zendy; Jad A. Khoury | Zendy; Farrin A. Manian | Zendy

Open Access

Efficacy of Oral Vancomycin in Preventing RecurrentClostridium difficileInfection in Patients Treated With Systemic Antimicrobial Agents: Table 1.

Author(s) -

Nicholas W. Van Hise,

Alex Bryant,

Erin Hennessey,

Andrew J. Crannage,

Jad A. Khoury,

Farrin A. Manian

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw401

Subject(s) - medicine , clostridium difficile , vancomycin , antimicrobial , odds ratio , incidence (geometry) , c difficile , confidence interval , antibiotics , microbiology and biotechnology , staphylococcus aureus , bacteria , genetics , physics , optics , biology

We compared rates of recurrent Clostridium difficile infection in patients receiving or not receiving oral vancomycin prophylaxis with systemic antimicrobial therapy. The incidence of C. difficile infection was significantly lower in patients receiving prophylaxis (4.2% vs 26.6% in those without prophylaxis; odds ratio, 0.12; 95% confidence interval, .04-.4; P < .001).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research